Enveric Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$17,291 over the previous period. Total operating expenses were $16,448,440.

Profit Margin

Enveric Biosciences, Inc. (NASDAQ:ENVB): Profit margin
2014 0 -33.64K
2015 15.97M -1.89M -11.83%
2016 36.14M -2.78M -7.69%
2017 48.59M -9.07M -18.67%
2018 42.99M -16.89M -39.3%
2019 39.91M -5.60M -14.04%
2020 0 -6.38M
2021 0 -48.97M
2022 0 -18.47M
2023 0 -17.29K

ENVB Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
000039.91M42.99M48.59M36.14M15.97M0
Cost of revenue
408.03K435.20K681.61K120.87K31.76M34.01M38.35M29.60M10.22M0
Gross profit
-408.03K-435.20K-681.61K-120.87K8.15M8.98M10.23M6.53M5.75M0
Operating exp.
Research and development
7.25M8.02M4.78M174.08K000000
Selling and marketing
000012.20M00417.24K119.84K0
Total operating expenses
16.44M19.96M25.94M5.61M14.47M13.69M21.72M10.33M5.96M32.81K
Operating income
-16.44M-27.41M-64.62M-5.61M-6.32M-7.14M-11.97M-5.37M-1.87M-32.81K
Other income (expenses), net
-814.37K7.45M8.19M-1.24M1.10M-5.10M-11.46M-1.97M-1.22M0
Income before tax
-17.26M-19.95M-56.43M-6.86M-5.21M-10.54M-11.46M-6.52M-2.01M-32.81K
Income tax expense
28.91K-1.48M-7.45M-477.73K388.65K6.34M-2.39M-3.74M-128.46K833
Net income
-17.29K-18.47M-48.97M-6.38M-5.60M-16.89M-9.07M-2.78M-1.89M-33.64K
Earnings per share
Basic EPS
-8.09-12.77-103.69-55.5-211.99-3.55K-3.02K-1.06K-856.06-192.25
Diluted EPS
-8.09-12.77-103.69-55.5-211.99-3.55K-3.02K-1.06K-851.69-192.25
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source